Skip to main content
. Author manuscript; available in PMC: 2014 Jul 21.
Published in final edited form as: Curr Opin Rheumatol. 2011 Mar;23(2):192–202. doi: 10.1097/BOR.0b013e3283438e13

Table 4.

Medications as a Risk Factor for gout

Author year [reference] Incident/
prevalent
gout
Medications as a risk Factor Odds ratio (OR), Risk ratio (RR) or
Hazard ratio (HR), Incidence Rate
Ratio (IRR) [95% CI]
Bhole et al., 2009 (11) incident Diuretic use vs. no diuretic use RRc for incident gout: Women, 2.39
[1.53–3.74]; Men, 3.41 [2.38–4.89]
Chen et al.,2003 (14)  prevalent Diuretic use vs. no diuretic usea  
Hunter et al., 2006 (36) prevalent Any diuretic use vs. none OR of gout flares, 3.6 [1.4–9.7]
Hunter et al., 2006 (36) prevalent Loop Diuretics use vs. no loop diuretic use OR of recurrent gout attacks, 3.8
Hunter et al., 2006 (36) prevalent Thiazide diuretics vs. no thiazide OR of recurrent gout attacks, 3.2
Janssens et al., 2006 (37) incident Diuretic use vs. no diuretic use IRR of incident gout, 0.6 [0.2–2.0]
Choi et al., 2005 (16) incident Diuretic use vs. none RR of gout flare, 1.77 [1.42–2.20]
Lin et al., 2000 (40) incident Use of diuretics during follow up vs. none OR of incident gout, 6.47 [2.03–18.8]
Stamp et al , 2006 (51)  prevalent Use of loop diuretics vs. none  Not specified
Suppiah et al., 2008 (52) prevalent Diuretic use vs. no diuretic use OR of prevalent gout 3.2; [.6–6.6]
Creighton et al., 2005 (28) incident HIV positive patients on Ritonavir vs. not OR of incident gout, 22 [5–104]
Gurwitz et al., 1997 (32) prevalent Non-thiazide antihypertensive vs. none RR for initiation of anti-gout therapy
1.00 [0.65–1.53]
Shoji et al., 2004 (49)  prevalent Antihyperuricemic drug use vs. none OR of gout flare, 0.22 [.10-.47]
Kang et al., 2008 (38) prevalent Colchicine prophylaxis (yes vs.no) OR of gout flare, 0.16 [0.04–0.61]b
Abbott et al., 2005 (5) incident Use of Neoral vs. Tacrolimus HR of incident gout, 1.25 [1.07–1.47]

Stamp et al , 2006 (51) and Shibolet et al., 2004 (48) assessed risk with medication use, but did not provide risk ratio

a

p-value <0.001;

b

p-value =0.008

c

Adjusted for age, education level, body mass index (BMI), alcohol consumption, hypertension, use of diuretics, blood glucose level, blood cholesterol level and menopausal status